NCT02284867

Brief Summary

Research question: Population of study: women diagnosed as term pregnancy in labor (control) and the other group diagnosed as preterm labor (cases). Intervention: measuring uterine natural killer cells . Outcome: uterine natural killer cells has a role in initiation of preterm labor. Research hypothesis:

  • Are uterine Natural Killer cells involved in the initiation of preterm labor ? Medical Application:
  • Possibility of prediction of preterm labor by assessment of Natural killer cells as well as preventing preterm labor by suppressing their activity .

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2012

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

November 2, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 6, 2014

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

February 4, 2016

Completed
Last Updated

February 4, 2016

Status Verified

January 1, 2016

Enrollment Period

2.3 years

First QC Date

November 2, 2014

Results QC Date

December 23, 2014

Last Update Submit

January 5, 2016

Conditions

Keywords

uterine natural killer cellsCD16CD56Preterm labour

Outcome Measures

Primary Outcomes (1)

  • Uterine Natural Killer Cells In Preterm Labor

    Number of participants with CD16 orCD 56 uterine Natural Killer Cells positive staining of placental sample

    2 years

Secondary Outcomes (1)

  • Comparison of CD16+ CD56 Dim Uterine Natural Killer Cells (uNK) Prevalence in Decidua vs. Villi in Placenta of Both Study Groups

    2 years

Study Arms (2)

Preterm labor

Patients who has threatened preterm labor and will receive tocolysis and these patients will either not respond to tocolysis and delivered preterm or will respond to tocolysis and will deliver at term .

Other: immunohistochemistry study

Term labor

Patient delivered vaginally at term with no history of having tocolysis for preterm labor at the current pregnancy .

Other: immunohistochemistry study

Interventions

After taking informed written consent,a placental sample will be taken either the patient delivered preterm or at term (term patients will be either control term group or patients with successful treatment of preterm labor). The placental sample taken should have part of the decidua and then the sample will be fixed in 10% neutral-buffered formalin for 24-48 h, routinely processed, embedded in paraffin wax, sectioned at 3 μm thickness, and mounted on 3-aminopropyl-triethoxysilane -coated slides. Serial sections will be immunostained for CD 16 and CD56 . immunohistochemistry study will be done at Ain Shams Maternity Hospital Histopathology department.

Preterm laborTerm labor

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

The patients will be recruited from women attending casualty at Ain Shams University Maternity Hospital.

You may qualify if:

  • Maternal age: 18-35 years old (to decrease the incidence of preterm labor related to age factor).
  • Women who present with viable pregnancy (between 28 and 37 weeks' gestation), and having a threatened preterm labor (which is defined as ≥ 2 uterine contractions at 28-37 weeks' gestation, The onset of labor may be determined by documented uterine contractions (at least one every 10 minutes) and ruptured fetal membranes or documented cervical change with an estimated length of less than 1cm or cervical dilation of more than 2 cm. Threatened preterm labor may be diagnosed when there are documented uterine contractions but no evidence of cervical change.

You may not qualify if:

  • Multiple pregnancy.
  • Documented uterine anomalies.
  • Oligohydramnios and polyhydramnios .
  • Medical disorders as Diabetes mellitus and hypertension.
  • Preterm premature rupture of membranes.
  • Conditions that may have an influence on immune reaction e.g. history of chorioamnionitis.
  • Smoking as a risk factor for preterm labor.
  • Patients having Autoimmune disorder as it may affect Uterine NK( natural killer ) cells level .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Koga K, Cardenas I, Aldo P, Abrahams VM, Peng B, Fill S, Romero R, Mor G. Activation of TLR3 in the trophoblast is associated with preterm delivery. Am J Reprod Immunol. 2009 Mar;61(3):196-212. doi: 10.1111/j.1600-0897.2008.00682.x.

    PMID: 19239422BACKGROUND
  • Murphy SP, Hanna NN, Fast LD, Shaw SK, Berg G, Padbury JF, Romero R, Sharma S. Evidence for participation of uterine natural killer cells in the mechanisms responsible for spontaneous preterm labor and delivery. Am J Obstet Gynecol. 2009 Mar;200(3):308.e1-9. doi: 10.1016/j.ajog.2008.10.043. Epub 2008 Dec 27.

    PMID: 19114277BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

a placental sample will be taken either the patient delivered preterm or at term (term patients will be either control term group or patients with successful treatment of preterm labor). The placental sample taken should have part of the decidua and then the sample will be fixed in 10% neutral-buffered formalin for 24-48 h, routinely processed, embedded in paraffin wax, sectioned at 3 μm thickness, and mounted on 3-aminopropyl-triethoxysilane -coated slides. Serial sections will be immunostained for CD 16 and CD56 . Immunohisto-chemistery study will be done at Ain Shams Maternity Hospital Histopathology department.

MeSH Terms

Conditions

Obstetric Labor, Premature

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Results Point of Contact

Title
Ahmed Mohammed Abass , Ass.lecturer in faculty of medicine
Organization
Ain Shams university (AinShamsU)

Study Officials

  • Murad Elsaed, proffesor

    +02-01223165820

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
4 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

November 2, 2014

First Posted

November 6, 2014

Study Start

August 1, 2012

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

February 4, 2016

Results First Posted

February 4, 2016

Record last verified: 2016-01